Erucic acid (22:1) was chosen as a marker to study triacylglycerol (TAG) biosynthesis in a Brassica napus L. cv Reston microspore-derived (MD) embryo culture system. TAGs accumulating during embryo development exhibited changes in acyl composition similar to those observed in developing zygotic embryos of the same cv, particularly with respect to erucic and eicosenoic acids. However, MD embryos showed a much higher rate of incorporation of 14C-erucoyl moieties into TAGs in vitro than zygotic embryos. Homogenates of early-late cotyledonary stage MD embryos (14-29 days in culture) were assessed for the ability to incorporate 22:1 and 18:1 (oleoyl) moieties into glycerolipids.
Few dicotyledonous oilseed crops have been amenable to the induction of high frequencies of embryogenesis in vitro. However, early studies using small numbers of anther-derived embryos of Brassica campestris revealed that 22:1 was present, and it was suggested that such gametophytic embryos might be utilized to study storage lipid biosynthesis (18) . MD embryos have been obtained from several plant species, including Brassica napus (19) , Hordeum vulgare (21) , and Nicotiana rustica (46) . Although the process is genotypedependent, it is possible to produce thousands of embryos at particular developmental stages from microspores isolated from immature inflorescences of certain B. napus genotypes (19, 33, 36) .
In our laboratories, we are interested in the analysis of seedspecific processes associated with the accumulation of storage lipids, particularly those rich in 22:1, in Brassica, and other oilseed species. A greater understanding of these processes may permit modification of seed oil biosynthesis, both quantitatively and qualitatively, through the expression of foreign genes in a seed-specific manner. Thus, we have been investigating the B. napus MD embryo system as a possible model for oilseed development. Preliminary investigations into lipid biosynthesis in the MD system have shown these haploid embryos to be very active in the synthesis and metabolism of erucoyl moieties (48, 50) . Here [1-'4C] erucoyl-CoA and [ 1-'4C]oleoyl-CoA by an enzymatic method described previously (49) . [2-'4C]Malonyl-CoA (55 mCi. mmol-') and [1-'4C] trioleoyl-glycerol (112 mCi-mmol-') were purchased from Amersham, while L-[2-3H(N)]G-3-P (10.6 Ci mmol-') was acquired from New England Nuclear.
Dierucin and diolein, each enriched in the sn-1,2 isomer (NuChek Prep, Inc., Elysian, MN), were purified and separated from their sn-1,3 isomers by TLC on Silica 60 G (E. Merck, Darmstadt, FRG) impregnated with 10% w/w boric acid (16) . The 1,2-DAGs were scraped from the plates and eluted from the silica with water-saturated diethyl ether. The ether extract was backwashed with ice water to remove traces of boric acid and then dried over anhydrous sodium sulfate. After removing the ether under a stream of nitrogen, the DAGs were redissolved in hexane and stored at -80°C.
1,2-Dioleoyl,3-erucoylglycerol was synthesized from 1,2-diolein (15 gmol) by condensation with erucoyl chloride (20 ,gmol) in the presence of 0.75 mL benzene:pyridine (1:1, v/ v). After stirring the reaction mixture under nitrogen for 18 h at 50°C, most of the solvent was evaporated, 0.2 mL water was added, and the TAG extracted with hexane. The hexane extract was backwashed repeatedly with 0.5 M NaHCO3 to remove traces of pyridine. The TAG product was purified by TLC on Silica Gel G in hexane:diethyl ether (80:20, v/v) and the structure of the intact TAG (M+ = 941) confirmed by direct probe El-MS (see below). In addition, the acyl composition was checked by transmethylation followed by GC analysis of FAMEs (see below). Numerous other racemic mixedacyl TAGs, not commercially available, were required as standards for HPLC and MS. These were synthesized, purified, and characterized by similar procedures using the necessary mono-or diacylglycerols and acyl chlorides as starting materials. 1,2-Dierucoyl-PA was synthesized via the corresponding PC as follows: 1,2-dierucin (10 gmol) was reacted with 0.65 mL CH2Cl2:pyridine:phosphorous oxychloride (95:95: 10, v/ v/v), with stirring, for 1 h at 4°C, followed by 1 h at 25°C. Dry choline chloride (200 mg) was added, and the reaction mixture was stirred overnight at 30°C. Water (20 AL) was added, and the reaction stirred an additional 30 min at 30°C. Solvents were evaporated, and the 1,2-dierucoyl-PC was extracted into 12 mL CH2Cl2:MeOH:water:acetic acid (50:39:10:1, v/v/v/v) and partitioned with 4 mL 4 N ammonia. After centrifugation, the lower organic layer was saved, the aqueous phase re-extracted with CH2Cl2:MeOH (2:1, v/ v), and the organic phases combined and dried under nitrogen. Dierucoyl-PC was hydrolyzed using phospholipase D (16) to yield dierucoyl-PA, which was purified by TLC on Silica Gel 60 H (E. Merck) in CH2Cl2:pyridine:formic acid (50:30:7, v/v/v). A portion of the 1,2-dierucoyl-PA was reacted with phospholipase A2 from Naja naja venom (16) to yield sn-1-erucoyl-LPA, which was purified by TLC using the solvent system described for PA. All other neutral lipid substrates were obtained from NuChek Prep Inc. 2-BrO was purchased from Dixon Chemicals (Sherwood Park, Alberta, Canada). All Microspores were isolated and cultured as described previously (50) . MD Both endogenous TAGs, isolated from MD embryos as described above, and '4C-labeled TAGs, products of in vitro biosynthesis experiments (described below), were analyzed by direct probe-MS using a VG 70-250 SEQ hybrid mass spectrometer (VG Analytical, Wythenshawe, Manchester, UK) in the El mode at an electron energy of 70 eV. Samples were introduced through the solids probe, which was then heated to 330°C. The source temperature was 250°C. Spectra were acquired by scanning from m/z 1300 to m/z 100 every 10 s, with a 0.5-s settling time. Daughter ion spectra were generated in the third field-free region with argon as the collision gas. The pressure in the collision cell was 5 x 10-5 torr, and the collision energy was 15 to 20 V.
TAGs were also analyzed by GC-MS on a Hewlett Packard model 5890 gas chromatograph interfaced to the VG 70-SEQ hybrid mass spectrometer. The GC was fitted with a Chrompack TAG Analysis Phase column (25 m x 0.25 mm, film thickness 0.1 ,um; 50% phenyl:50% methyl polysiloxane; Chrompack, Middelburg, The Netherlands). GC conditions were as follows: cold on-column injection; oven temperature 360°C, isothermal; carrier gas, helium 50 cm/s. Mass spectrometer conditions were as follows: El mode, at an electron energy of 70 eV; source temperature 235°C; re-entrant temperature 400°C. Spectra were acquired by scanning from m/ z 1300 to m/z 100 every 3 s/decade, with a 0.5-s settling time.
DAGs were silylated using 20 ,uL 
Preparation of Homogenate and Differential Centrifugation Fractions
Mid-late cotyledonary stage MD embryos were harvested, rinsed thoroughly with distilled water, and gently suctionfiltered to remove excess water. After weighing, embryos (1-3 g fresh weight) were homogenized at 4°C by gentle grinding with a mortar and pestle in the presence a small amount of acid-washed silica sand and 100 mM Hepes-KOH, pH 7.4, containing 0.32 M sucrose, 1 mM EDTA, and 1 mM DTT. A ratio of 4 to 5 mL grinding medium-g-' fresh weight was used. The homogenate was filtered through two layers of Miracloth (Calbiochem, La Jolla, CA) and the cell-free extract was utilized directly for in vitro studies of lipid biosynthesis. Subcellular fractionation of the homogenate was performed by differential centrifugation. All g forces cited are average values. The homogenate was centrifuged at 10,000 x g for 20 min using a Sorvall model RC2-B centrifuge equipped with a Sorvall SM-24 rotor (Ivan Sorvall, Inc., Norwalk, CT). The floating oil bodies were scooped up with the aid of a sterilized inoculum loop, and the residual fat pad material was recovered by aspiration. The oil bodies were resuspended in 5 to 6 mL grinding medium, overlayed with an equal volume of grinding medium containing 0.1 M sucrose, and recentrifuged at 1 8,000g for 15 min. This process of washing the oil bodies by floating them through a 0.1 M sucrose pad was repeated at least three times, or until the oil body fraction was creamy white in color. After the final centrifugation, the washed oil bodies were scooped up, resuspended in 1 to 2 mL grinding medium, and gently dispersed with a ground glass homogenizer. The original 10,000g pellet was washed by resuspension in 10 mL grinding medium followed by recentrifugation at 10,000g for 20 min. After two such washes, the final pellet was resuspended in 2 mL grinding medium. The 10,000g supernatant was centrifuged on a Beckman model L2-65B ultracentrifuge using a SW 4OTi rotor (Beckman Instruments, Inc., Palo Alto, CA) at 105,000g for 90 min. The pellet (microsomal fraction) was resuspended in 1 to 2 mL of grinding medium, while the supernatant ( Following a 5-min isocratic period at 100% acetone, the column was re-equilibrated to 50% acetone/50% acetonitrile over 5 min. The HPLC flow rate was 2 mL-min-'. The column eluate was split, with 10 to 20% going to the evaporative analyzer and the remainder going to the radioactive flow detector. Before entering the latter, the column effluent was mixed with scintillant (toluene plus 0.4% w/v 2,5-diphenyloxazole) at a rate of 2 mL min-'. Radiolabeled TAGs were identified by co-chromatography with external TAG standards detected with the evaporative analyzer, and were confirmed by direct probe MS of HPLC fractions.
Argentation-TLC of radiolabeled TAGs was performed on Silica Gel G impregnated with 10% (w/v) AgNO3 (16) in chloroform:MeOH (99:1, v/v). After locating radiolabeled spots on the TLC using the Berthold LB 285 Linear Analyzer, the TAG fractions were eluted and aliquots were characterized by GC-MS. Positional analyses were performed on radiolabeled TAGs by treatment with pancreatic lipase (16) and by a modified Brockerhoff stereospecific analysis essentially as described by Christie (16 After 2 to 6 h at 30°C, 100 rpm, reactions were stopped, phases separated, the TAG fraction isolated by TLC and intact TAGs analyzed by radio-HPLC as described above.
RESULTS AND DISCUSSION Comparison of Acyl Composition of Total Lipids and TAG Accumulation in Developing Microspore-Derived and Zygotic Embryos
The fatty acid composition of total acyl lipids isolated from developing MD Reston embryos showed a strong similarity to that observed in developing zygotic seeds of the same cv, particularly with respect to accumulation of the 18:1, 20:1, and 22:1 acyl moieties (Fig. 1) . In both MD and zygotic embryos, the mol % proportions of eicosenoic and erucic acids increased from 2 to 3% and 1 %, respectively, at early cotyledonary stages, to 9 to 13% and 12 to 15%, respectively, by late cotyledonary stages. In both embryo types, the proportion of 18:1 fell concomitantly with an initial rise in proportions of 20:1 followed by 22:1 during the later cotyledonary stages of embryogenesis. Such trends suggest that in MD embryos, 20:1 and then 22:1, are biosynthesized from oleoyl-CoA via successive condensations with malonyl-CoA, as is known for developing zygotic embryos of B. napus (43) , Brassica juncea (1), and other oilseeds (3, 28, 31, 34, 35) . Other major acyl groups present throughout embryogenesis in both microspore-derived and zygotic systems (data not shown) were 18:2, 18:3, and 16:0. The mol % proportions of these three fatty acids decreased from heart stage ( 18:2 = 31-32%, 18:3 = 14-18%, 16:0 = 8-17%) to very late cotyledonary stage (18:2 = 16-18%, 18:3 = 9-10%, 16 :0 = 4%). Freshly isolated Reston microspores had about 48% 18:3, 16% 18:2, and 15% 16:0, in addition to 18:1.
When compared on a dry weight basis, the acyl composition of lipids from very late cotyledonary stage MD embryos was similar to that of mature zygotic seed (Table I) . Total fatty acids comprised about 45% of the dry weight in both embryos, (50) .
In vivo rates of TAG biosynthesis, estimated from measurements of TAG, dry weight, and protein during the rapid phase of lipid accumulation, were compared in developing Reston zygotic embryos (4-8 weeks after anthesis) and MD embryos (2-5 weeks in culture). Zygotic and MD embryos accumulated TAGs at rates of 10.0 and 10.7 ,ug-min-' .mg dry weight-', and 75 and 142 pmol.min`' mg protein-', respectively. Thus, the rates were essentially identical when expressed on the basis of dry weight. While ofthe same order of magnitude, the difference in rates of TAG accumulation expressed on a mg protein basis may be due to inherent differences between zygotic and MD embryos in the accumulation of storage proteins (e.g. cruciferin) as reported previously (50) .
Further Analysis of Endogenous Acyl Lipid Species in Developing MD Embryos
Analyses of the fatty acid composition of acyl lipids in late cotyledonary stage MD embryos indicated the virtual absence of 22: 1, but the presence of significant 20: 1, in polar lipids and MAGs (Table II) . However, both erucoyl and eicosenoyl moieties were detected in comparable proportions in the TAGs, DAGs, and FFAs. The inability to detect 22:1 in the MD embryo polar lipid fraction agrees with comparable studies of zygotic embryos. In general, 22:1 does not accumulate in the phospholipid or membrane fractions of developing oilseeds, but is found almost exclusively in the neutral lipid fraction (2, 23, 29, 34, 38) . Eicosenoic acid has been reported to be detected in the PC fraction of Brassica campestris (22 (8, 1 1,  32) . Treatment of endogenous MD embryo TAGs with pancreatic lipase, followed by transmethylation of the FFAs released from the sn-1 and sn-3 positions and the remaining sn-2 acyl MAGs, confirmed that erucoyl moieties were present at the sn-1 + 3 positions but absent at the sn-2 position. This is supported by the data from TAG analyses by MS, which indicated that trierucin was not found in MD embryos of B. napus cv Reston. However, the presence of a detectable level of dierucoyl, monoeicosenoyl TAG in the EI-mass spectrum of endogenous TAGs (M+ = 1025; Fig. 2A) suggests that, at least in the MD embryo system, 20:1 moieties are not absolutely excluded from the sn-2 position of TAGs.
From the analyses of the endogenous acyl lipids of developing MD embryos, it was apparent that at the mid-late cotyledonary stage, 20:1 and 22:1 were synthesized and accumulated in the neutral lipid fraction and that the enzymatic machinery was in place for producing DAGs containing erucoyl moieties at the sn-1 position and TAGs containing 22:1 at both the sn-1 and sn-3 positions.
Comparison of in Vitro TAG Bioassembly in MD versus Zygotic Embryo Systems
Initial studies conducted utilizing homogenates and microsomal fractions prepared from late (29-d) cotyledonary stage MD embryos had indicated that, in the presence of G-3-P, radiolabeled erucoyl moieties were very rapidly incorporated into the TAG fraction, but the mechanism was not reported (50) . In the present study, MD and zygotic embryos were compared to see whether they could synthesize TAGs in vitro, utilizing radiolabeled erucoyl-CoA as an acyl donor and G-3-P as an acceptor, at rates that could support those estimated for TAG accumulation in vivo. While the zygotic embryo system incorporated erucoyl moieties poorly into TAGs in vitro, both homogenates and microsomal fractions prepared from the MD embryo system were highly active in this regard, exhibiting rates that could easily account for those observed in vivo (Table III) . The high rates of TAG biosynthesis observed in the presence of G-3-P and '4C-22: l-CoA in vitro in the MD embryo system also exceeded those reported in comparable studies utilizing homogenates or microsomal fractions prepared from various developing zygotic embryos, including B. napus (45) (Fig. 3A) . These data are consistent with oleoyl incorporation into TAGs via the Kennedy Pathway, as well as into membrane lipid components (e.g. PCs, PEs), as is known for zygotic oilseeds (7, 28, 30, 44, 45) . In particular, the rates of incorporation of 18:1 moieties into LPA, PA, and in developing safflower (25) and cultured rat hepatocytes (15, 26) , respectively. Thus, these chemicals were tested for their effects on the incorporation of radiolabeled erucoyl-CoA into acyl lipids in the MD embryo system. In the presence of G-3-P as acyl acceptor, 25 mM EDTA, 5 mm DIPFP, and 1.5 mM 2-BrO decreased the rate of incorporation of '4C-22:1 moieties into TAGs by 85%, 60%, and 80%, respectively, but in no case was the inhibition accompanied by an accumulation of '4C-22: 1 in lyso-PA, PA, DAG or other complex polar lipids. In contrast, a parallel experiment conducted utilizing "'C-18: 1-CoA in the presence of 2-BrO indicated that levels of "'C-18:1 in LPA/PA and DAG increased by 170% and 70%, respectively, whereas "'C-18:1 in TAGs decreased by 70%. Thus, the inhibitor data support the incorporation of oleoyl-CoA, but not erucoyl-CoA, into LPA, PA, and DAG when G-3-P is supplied as substrate.
Acceptor Studies and Analyses of Radiolabeled TAGs
G-3-P and a number of acyl lipids were tested as acceptors to probe the mechanism by which "'C-22: 1 was incorporated into TAGs. With the exception of DHAP, all substrates screened gave incorporation rates greater than that observed in the absence of exogenous acceptor (Fig. 4) and Tables were not determined and are not absolute. These short-form designations are for the purposes ofdiscussion and indicate only that these acyl moieties were present in the intact TAGs. Regardless of the actual stereospecific composition, TAGs containing identical acyl compositions (e.g. 18:2/18:1/22:1, 18:1/18:2/22:1) were not resolved by reversephase HPLC. Argentation TLC of radiolabeled TAGs (Fig. 6) followed by elution and GC-MS of radiolabeled fractions confirmed that, in the presence of G-3-P and '4C-22: l-CoA, only the four monoerucoyl ["'C]TAGs described above were produced in vitro.
Analyses of radiolabeled TAGs from "'C-18: 1-CoA incorporation experiments revealed species containing C18 moieties, the primary "'C products being LOL, LOO, and 000 (Fig. 7) . There was also some evidence for a small amount of LnOE, but this was not clearly resolved from 000 by the HPLC gradient. Transmethylation of the total radiolabeled TAG fraction showed a "'C-fatty acyl distribution of 76% '4C-18:1, 21 % "'C-18:2, and 3% "'C-18:3. There was no evidence of TAGs containing radiolabeled 20 Following elution from the silica, GC-MS analyses of the radiolabeled TAG fractions revealed the same four monoerucoyl TAG species identified by HPLC analysis (Fig. 5) .
supplied with G-3-P and either '4C-22: 1 -CoA or '4C-18:1-CoA, indicated that the radiolabeled erucoyl moieties were incorporated exclusively into the sn-3 position, while the oleoyl moieties were restricted to the sn-1 and sn-2 positions (Table IV) . Given the number of complex hydrolytic and synthetic steps involved in a stereospecific analysis (16) , the very small proportion of '4C-22: 1 detected at the sn-I position was well within the range normally attributed to limited acyl migration during product isolation at almost any stage of the method. The data suggested that, while all three acyltransferases of the Kennedy Pathway leading from G-3-P to TAGs (44) were operating in the MD embryo homogenate system, there was some degree of acyl-CoA specificity: erucoyl groups were inserted by DGAT into the sn-3 position, while oleoyl moieties were incorporated via G-3-P AT and LPAT, into the sn-I and sn-2 positions, respectively. The same stereospecific 14C-22: 1 distribution pattern was confirmed in a microsomal protein fraction. Furthermore, a homogenate from early (14-d) cotyledonary embryos gave similar results (Table IV) , indicating that such positional selectivity was not dependent upon the stage ofembryo development. The inability to detect radiolabeled oleoyl moieties on the sn-3 position of TAGs synthesized in the presence of G-3-P may indicate the high affinity for oleoyl-CoA exhibited by G-3-PAT and LPAT relative to DGAT, in late-cotyledonary stage MD embryos.
Erucoyl-CoA:DGAT Activity
The cumulative data suggested that when '4C-22:1-CoA was the substrate, erucoyl moieties were incorporated exclusively via a DGAT reaction. When sn-1,2-dierucin was supplied as an acyl acceptor, in addition to the monoerucoyl TAG species described above, the nonindigenous TAG trierucin was also produced, comprising about 25 to 35% of the radiolabeled TAG product (Fig. 4) . The presence of trierucin 10% going to a mass detector (evaporative analyzer; top panel) and the remaining 90% going to the radioactive flow detector (bottom panel). TAG species were identified by co-chromatography with external TAG standards, located using the mass detector. Abbreviations: LOE, LnOE, etc.: TAG species composed of erucoyl (E), eicosenoyl (Ei), linoleoyl (L), linolenoyl (Ln), oleoyl (0), and palmitoyl (P) moieties. a tr = Trace (<10%).
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was confirmed by radio-HPLC and by direct probe El-MS of the radiolabeled TAG fraction, which showed a molecular ion at m/z = 1053 (data not shown).
There is current interest in genetic modification of rapeseed to produce seed oils very high in 22:1, by introducing into B. napus a foreign LPAT that is capable of inserting erucoyl moieties at the sn-2 position. Recent studies in this laboratory (47) and others (14) have shown that whereas B. napus is essentially devoid of an active erucoyl-CoA:LPAT, meadowfoam species (Limnanthes douglasii [47] and Limnanthes alba [14] ) possess a highly specific erucoyl-CoA:LPAT. Thus, the meadowfoam LPAT would appear to be an excellent candidate for supplying a target gene to genetically engineer rapeseed to produce trierucin. However, the final success of such a program would depend on whether, for example, B. napus DGAT is capable of acting on dierucoyl-DAG. The metabolic studies reported here, where ['4C]trierucin is produced in the presence of sn-1,2-dierucin and '4C-22: 1 -CoA, would suggest that the B. napus DGAT is able to catalyze such a conversion.
When sn-1,2-dierucin or -diolein was tested as acceptor in the presence of 2-BrO, incorporation of '4C-22: 1 into TAGs was inhibited by 70% to 80% (Table V) . To our knowledge, this is the first report of the use of this chemical to inhibit DGAT activity in oilseed metabolism studies, although its effects have been documented in animal systems (15, 26) . It has been suggested that the inhibition of DGAT by 2-BrO in mammalian systems is, in fact, accomplished by the corresponding 2-BrO-CoA thioester, synthesized in vitro from 2-BrO via a mitocondrial acyl-CoA synthetase (26). While we have shown that a long-chain acyl-CoA synthetase activity is present in the B. napus MD embryo system (50), it is not yet clear whether 2-BrO or its CoA thioester is the active inhibitor of the DGAT in this system. Nevertheless, 2-BrO-CoA may prove to be a more potent inhibitor of DGAT in vitro, and we are investigating this possibility. The specific activity of DGAT expressed in homogenates varied depending on the acceptor substrate supplied (Table  V) . In addition, the relative rates observed between G-3-P and DAG acceptors differed somewhat depending on whether homogenates were prepared from early (Table V) or late (Fig.  4 ) cotyledonary stages.
In localization studies performed in late cotyledonary stage MD embryos using differential centrifugation, DGAT activity was found in oil body and microsomal fractions, but was essentially absent from the soluble (105,OOOg supernatant) fraction (Fig. 8) . A small amount of activity was also initially detected in the 10,000g pellet (data not shown), but after two rounds of washing in grinding medium followed by re-centrifugation at 10,000g to re-precipitate the protein, DGAT activity was lost from the pellet fraction. Thus the activity initially measured in this fraction was probably due to contamination from the microsomal fraction. The absence of significant DGAT activity in the soluble fraction was consistent with data reported for a similar fraction from zygotic B. napus, where 18:1 -CoA was the acyl donor supplied (30) . In the present study, about 65% of the total activity and about 7% of the total protein were recovered in the microsomal pellet, and this fraction yielded the highest specific activity of DGAT. The absolute activity expressed in this fraction was greater when G-3-P, rather than DAG, was supplied as acceptor (Table V) . In general, the activities recorded in the presence of DAG acceptors in this study were comparable to 22:1-CoA:DGAT activities recorded in microsomal preparations from zygotic embryos of high 22:1 cvs of B. napus (8, 13) .
However, the rate of incorporation of '4C-erucoyl moieties into TAGs in the presence of G-3-P was much greater in the MD embryo system than had been observed in parallel in (38, 40, 41) were the first to demonstrate that this enzyme existed in developing oilseeds. Subsequently, it was shown that safflower microsomes would catalyze the simultaneous movement of the DAG backbone into PC and the removal of glycerol moieties from PC to DAG during the synthesis of TAGs via the Kennedy Pathway; in short, the enzyme could operate in a reversible fashion (42) . Furthermore, CDP-choline and CMP, the cofactors of the forward and reverse reactions of CPTase, respectively, were not found to be ratelimiting in microsomal preparations of safflower (42 Figure 5 . While not unequivocal, these findings strongly suggested that the [3H] glycerol backbone originating in G-3-P was incorporated uniformly into all DAG species, via LPA and PA. Subsequently, '4C-erucoyl moieties were incorporated onto DAGs. Thus, the ratio of '4C/3H in each TAG species reflected the relative proportions of the individual endogenous DAG species available to accept '4C-erucoyl moieties.
To test whether G-3-P was capable of regulating the conversion of PC to DAG during TAG biosynthesis in vitro in the MD embryo system, a double label experiment was performed, examining the ability of 200 pM [3H]PC to act as an acyl acceptor for '4C-22: 1 -CoA, both in the absence and presence of unlabeled 500 MM G-3-P (Table VI, experiments B and C, respectively). These data were then compared with that obtained when 500 pM [3H]G-3-P was tested alone as an acceptor for '4C-22: l-CoA (Table VI, CThese ratios reflect the relative proportions of 14C-labeled TAG species depicted in Figure 5 .
[3H]PC alone ( (44) .
In Table VI , experiment C, the unlabeled glycerol backbone would be expected to move from G-3-P to LPA, PA, and then DAG via the typical Kennedy Pathway, as in Table VI B and C). This was presumably due to the activity of phospholipase D in the homogenate. This enzyme is known to be present in developing seeds (16, 39) . However, the proportion of 3H in LPA plus PA (approximately 15%) resulting from the hydrolysis of [3H]PC, remained constant in the presence (Table VI, experiment C) or absence (Table VI, experiment B) of G-3-P. Proportions of 3H in LPA plus PA were not significantly diluted by the relative excess of unlabeled G-3-P, yet 'H in PC decreased, whereas that in TAGs increased.
These trends add further credence to the argument that the main effect of G-3-P in the presence of [3H]PC was to directly stimulate transfer of acylated glycerol backbones from PC to DAG pools via CPTase, followed by conversion of DAGs into TAGs via DGAT.
If Kennedy Pathway intermediates can also affect this interconversion in a manner similar to G-3-P, this could explain the similar 14C TAG patterns observed regardless of the acyl "acceptor" tested. The DAGs, released from an endogenous PC pool, would reflect the acyl composition of the latter, regardless of the exogenous acceptor supplied. These DAGs would then be expected to incorporate '4C-22: 1 moieties into the sn-3 position via the DGAT reaction, always yielding the same radiolabeled TAG pattern. Clearly, an exception to this general trend would arise only in a situation in which an exogenous DAG substrate such as the unnatural sn-1 ,2-dierucin was supplied. In this case, in addition to the TAGs arising from the endogenous DAG acceptor pool, one would also expect to see some radiolabeled trierucin produced, as was observed (Fig. 4) .
Test of Postsynthetic Modification of Preformed TAGs
Since erucoyl moieties are found endogenously in the sn-1 position of TAGs from both B. napus MD embryos (this study) and zygotic embryos (8, 11, 32) , further investigations were conducted to examine mechanisms by which this might be accomplished. It has been proposed that TAGs containing very long-chain fatty acids at the sn-1 position are biosynthesized via a postsynthetic modification or acyl exchange on preformed TAGs (20, 27, 28 ), yet to our knowledge, this hypothesis has not been directly tested in vitro. In the present study, when supplied with sn-1,2 dioleoyl-sn-3 erucoylglycerol and '4C-22: 1 -CoA, MD embryo homogenates were unable to produce ['4C]dierucoyl TAGs (Fig. 9) . In similar experiments (data not shown), tests of: (a) [ lipids possessing similar characteristics to those found in developing zygotic embryos of the same cv. In vitro, in the presence of G-3-P, homogenates prepared from the MD embryos are capable of TAG bioassembly, incorporating '4C-18:1 moieties into the sn-1 and -2 positions, while '4C-22:1 moieties from erucoyl-CoA are rapidly and specifically inserted into the sn-3 position of TAGs via a highly active erucoyl-CoA:DGAT. DGAT activity was localized primarily in a microsomal fraction. While attempts have failed to isolate from Brassica species, microsomal fractions capable of significant incorporation of radiolabeled erucoyl moieties into TAGs in the presence of G-3-P (4, 22, 43, 44), a microsomal preparation from B. napus MD embryos is highly active in this regard. G-3-P and a number of acyl lipids appear to enhance erucoyl-CoA:DGAT activity. Preliminary evidence suggests that G-3-P may facilitate the release of DAG acceptors from a PC pool via a direct stimulation of CPTase activity. It is also possible that G-3-P is acting as an allosteric effector of DGAT. However, this hypothesis can only be tested upon purification of the enzyme. The microspore-derived embryo system is an attractive alternative to zygotic embryos as an enzyme source for studies of lipid biosynthesis enzymes. It is easy to obtain specific developmental stages that exhibit high capacities for lipid biosynthesis in vitro. 
